There is 1 paper on new-onset type 2 diabetes mellitus in aging research: 1 observational study in people.
1 paper studies it12 more mention it1 finding
2 new papers in 30 daysSee all 13 papers on new-onset type 2 diabetes mellitus
“Atorvastatin 40 mg was associated with modestly lower rates of both incident HF and new-onset T2DM compared to 80 mg.”
- Humans1
Associations
1Atorvastatin
downin humans1RR 0.94
1 study
Atorvastatin
downin humans1RR 0.94
Atorvastatin is associated with new-onset type 2 diabetes mellitus in humans (stable coronary artery disease; propensity score-matched cohorts) (12.1% versus 12.8%; RR 0.94, 95% CI 0.92–0.96; HR 1.02, 95% CI 1.00–1.05; log-rank p=0.053).
“Atorvastatin 40 mg was associated with modestly lower rates of both incident HF and new-onset T2DM compared to 80 mg.”
Humansstable coronary artery disease; propensity score-matched cohorts40 mg versus 80 mg71% males
AHA Scientific Sessions 2026 abstract
Latest
7 papers in 12 monthsAHA Scientific Sessions 2026 Abstract
Heart Failure and Diabetogenic Risk with Atorvastatin 40 mg versus 80 mg in Stable CAD: A Large-Scale Real-World Evidence Study
Cohort study of 176,262 peopleAtorvastatin
Frontiers in Endocrinology
Longitudinal Association of Triglyceride-Glucose Related Indices with New-Onset Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease Comorbidity: A Prospective Cohort Study
Accepted, not yet published: cohort study of 6,717 peopleMetabolic dysfunction-associated steatotic liver disease
medRxiv
New-onset type 2 diabetes mellitus and obesity-related cancer risk: a matched cohort study (UK Biobank)
Preprint: cohort study of 71,170 peopleObesity-related cancer
Geriatrics & Gerontology International
Increased 30-s Arm Curl Frequency Can Reduce the Risk of Type 2 Diabetes Mellitus in Older Adults: A Cohort Study From Wuhan, Central China
Cohort study of 2,094 peopleType 2 diabetes
Endocrine Practice
Denosumab and Risk of Type 2 Diabetes Risk Among Patients With Osteoporosis: A Retrospective Cohort Study
Cohort study of 20,735 peopleDenosumab
Endocrine
Data-driven cluster analysis of lipids, inflammation, and aging in relation to new-onset type 2 diabetes mellitus
Cohort study of 7,402 peopleType 2 diabetes
Current Opinion in Lipidology
Cholesteryl ester transfer protein inhibition: a pathway to reducing risk of morbidity and promoting longevity
ReviewInterventions